Transcription factor TFIIA is controlled by complex regulatory networks including proteolysis by the protease Taspase 1, though the full impact of cleavage remains elusive. Here, we demonstrate that in contrast to the general assumption, de novo produced TFIIA is rapidly confined to the cytoplasm via an evolutionary conserved nuclear export signal (NES, amino acids 21 VINDVRDIFL 30 ), interacting with the nuclear export receptor Exportin-1/chromosomal region maintenance 1 (Crm1). Chemical export inhibition or genetic inactivation of the NES not only promotes TFIIA's nuclear localization but also affects its transcriptional activity. Notably, Taspase 1 processing promotes TFIIA's nuclear accumulation by NES masking, and modulates its transcriptional activity. Moreover, TFIIA complex formation with the TATA box binding protein (TBP) is cooperatively enhanced by inhibition of proteolysis and nuclear export, leading to an increase of the cell cycle inhibitor p16 INK , which is counteracted by prevention of TBP binding. We here identified a novel mechanism how proteolysis and nuclear transport cooperatively fine-tune transcriptional programs.
Introduction
Transcription factors are intimately involved in the regulation of gene expression and thus, crucial for all living organisms (Orphanides et al., 1996; Lee and Young, 2000) . They constitute the single largest family of human proteins, covered by ∼10% of genes in the genome (Babu et al., 2004) . In eukaryotes, an important ubiquitous class of transcription factors called general transcription factors (GTFs) is necessary to maintain basal gene expression (Reese, 2003) . The most common GTFs necessary to reconstitute accurate transcription from a minimal promoter of class II protein coding genes are TFIIA, B, D, a complex composed of the TATA box binding protein (TBP) and TBPassociated factors (TAFs), as well as TFIIE, F, and H (Burmeister et al., 2006) . Together with RNA polymerase II, these factors are responsible for promoter recognition by formation of the socalled preinitiation complex (PIC) capable of initiating RNA synthesis from a DNA template core promoter region, the key event of transcription initiation (Orphanides et al., 1996; Lee and Young, 2000) . With regard to TFIID, in vitro only TBP is necessary for general transcription of TATA box-containing promoters, whereas TAFs are responsible for adding promoter selectivity (Bieniossek et al., 2013) . TAFs are included in two distinct, nonequivalent complexes, TFIID and B-TFIID, with the TFIID complex containing TBP and more than eight TAFs. The majority of TBP is present in the B-TFIID complex, which is further constituted by only one TAF, TAFII170/BTAF1 (Dynlacht et al., 1991; Timmers et al., 1992; Lee and Young, 2000) . Recent structural studies demonstrated that indeed all core promoter elements are contacted by subunits of TFIID, and TFIIA bridges the TBP-TATA complex with lobe B of TFIID Louder et al., 2016) . Competition of TAF complexes with the binding of TFIIA and DNA to TBP, involving conformational rearrangements within TFIID, regulates timing and rate of PIC assembly. In contrast to TFIID, TFIIA does not bind DNA itself, its interactions with TBP rather allow the formation and stabilization of the PIC by correct positioning and retaining of the DNA over the Pol II cleft (Plaschka et al., 2016) . However, binding of TFIIA to TBP is mutually exclusive with binding of some negative regulatory proteins (Deng et al., 2009) , thus assigning TFIIA the function of an anti-repressor (Aperlo et al., 1996) . It results in stabilizing TFIID binding by exclusion of negative factors that might otherwise bind to TBP to remove it from the DNA or interfere with PIC formation (Yokomori et al., 1994; Gaston and Jayaraman, 2003; Hoiby et al., 2007) . TBP is in turn responsible for the recruitment of the RNA polymerase II holoenzyme, the final event in transcription initiation (Lee and Young, 2000) . Additionally, TFIIA may act as a coactivator for some transcriptional activators (Yokomori et al., 1993; Ozer et al., 1994; Kobayashi et al., 1998; Kraemer et al., 2001) , assisting with their ability to regulate spatiotemporal expression of specialized genetic programs (Kobayashi et al., 1995; Lieberman et al., 1997; Stargell et al., 2000) . Albeit TFIIA is not a real basal transcription factor due to growing evidence for a broader function in transcriptional regulation (Hoiby et al., 2007) , genetic analysis in yeast has shown that TFIIA is essential for viability (Kang et al., 1995) . Moreover, recent data indicates an involvement of TFIIA in gene expression regulation by TBP-related factors (TRFs) (Reina and Hernandez, 2007; Zehavi et al., 2015) . Especially the TBP-like protein (TLP) was shown to exhibit the highest affinity to TFIIA among known proteins, exceeding that of TBP to TFIIA by one order of magnitude (Teichmann et al., 1999; Nakadai et al., 2004) . This engages TFIIA in the stabilization of TLP, which normally underlies constant degradation by the ubiquitin-proteasome system (Isogai et al., 2016) .
In higher eukaryotes, TFIIA is composed of three subunits, α, β, and γ of ∼35, 19, and 12 kDa, respectively, encoded by two separate genes (Hoiby et al., 2007) . The γ-subunit is encoded by a single gene (TFIIAγ, TFIIAS, TOA2; gene name GTF2A2) (Ozer et al., 1994; DeJong et al., 1995) and conserved among different species, whereas sequence similarity in TFIIAαβ is limited mostly to the N-terminal region of the α-subunit and the C-terminus covering most of the β-subunit (Ranish et al., 1999) . TFIIAαβ is encoded by another gene (TFIIAL, TOA1; gene name GTF2A1) encoding for one common 55 kDa precursor, which is post-translationally processed into two smaller, extremely acidic subunits (DeJong and Roeder, 1993) . Of note, a second gene encoding a large TFIIA subunit, ALF/TFIIAtau (gene name GTF2A1LF), has been described as germ cell-specific TFIIA-like factor in some higher eukaryotes (Ozer et al., 2000) . Moreover, the GTF2A gene gives rise to in total four transcripts, only two of which are with 376 amino acids (aa) (TFIIA wt/isoform 1) and 337 aa (isoform 2) protein coding, whereas the 59 aa variant most likely is subjected to nonsense mediated decay and the transcript with a retained intron sequence is not expressed. Isoform 2 is generated from an alternative transcription start site and thus lacks the N-terminus of wild-type (wt) TFIIA comprising aa 1-39 (Hoiby et al., 2007) .
When TFIIA cleavage was first reported (Weideman et al., 1997) , it had been generally assumed that uncleaved TFIIA is the inactive precursor and cleavage occurs to activate TFIIA for transcription. The enzyme responsible for TFIIA proteolysis is Taspase 1 (Zhou et al., 2006) , a protease encoded by the TASP1 gene and involved in cleavage of the leukemic proto-oncogene MLL (Hsieh et al., 2003) . The intrinsic Taspase 1 cleavage site of  human TFIIA, 272 QVDGTGD 278 , perfectly fits the recently rede- (Bier et al., 2011a) . It is remarkably conserved in different evolutionarily distinct species (Geiger et al., 1996; Tan et al., 1996; Bleichenbacher et al., 2003) as well as in the germ cell-specific TFIIA-like factor ALF (Hoiby et al., 2004) . Both uncleaved αβ and cleaved α-and β-subunits can be found in association with the TFIIA γ-subunit in vivo (Mitsiou and Stunnenberg, 2000; Hoiby et al., 2007) , and both forms interact with TBP on DNA and support transcription to similar extents in vitro and in reporter assays (Sun et al., 1994; Hoiby et al., 2004) . However, in vivo uncleaved TFIIAαβ in conjunction with TFIIAγ can assemble with TBP into the so-called TBP-TFIIA containing complex (TAC) lacking classical TAFs in a p300-facilitated manner (Hoiby et al., 2007) , presumably activating so far unspecified embryo-specific promoters. Uncleaved TFIIAαβ/γ might also induce bulk transcription during development, possibly via TFIID. , in turn halting cell cycle progression in G1 and S phase (Takeda et al., 2015) . The observation that cleavage is the prerequisite for proteasomal degradation of TFIIA (Hoiby et al., 2004) indicates that cleavage regulates TFIIA protein levels and may thus play a role in transcription. Whereas cleavage of TFIIA occurring at residues 274 D/G 275 leaves D
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the C-terminal residue of the α-subunit, besides G 275 , D 278 was reported to be the primary N-terminal residue of the β-subunit (Zhou et al., 2006) . This might be probably generated by a secondary, so far unknown either endo-or exopeptidase removing three more aa. This yields D 278 as the destabilizing N-terminus for the destruction pathway and might thus be part of an intricate regulatory circuitry to fine tune the level of TFIIA. Another sophisticated way of governing protein activity is the controlled distribution of macromolecules within different cellular compartments. One fundamental yet defining feature of eukaryotic cells is their spatial and functional division into the nucleus and the cytoplasm by the nuclear envelope, a double lipid membrane that is perforated by nuclear pore complexes (Gorlich and Mattaj, 1996) . Nucleocytoplasmic transport takes place through these nuclear pores and is tightly regulated by specific signals and transport receptors, constituting a specific and selective bidirectional transport machinery (Gorlich and Mattaj, 1996; Gorlich and Kutay, 1999) . In general, active nuclear import requires energy and is mediated by short stretches of basic aa, termed nuclear localization signals (NLS), which interact with specific import receptors (Bier et al., 2011a) . By contrast, signal mediated nuclear export pathways (Lei and Silver, 2002; Guttler and Gorlich, 2011) are less understood. The best-characterized nuclear export signals (NES) consist of a short leucine-rich aa stretch, interact with the export receptor Crm1 (Knauer et al., 2005a) and depend on the RanGTP/GDP axis. Leucine-rich NES have been identified in an increasing number of cellular and viral proteins executing heterogeneous biological functions. These include RNA transport (Cullen, 2003) , cell cycle (Porter and Donoghue, 2003) , as well as transcription control (Cartwright and Helin, 2000; McBride and Reich, 2003) . Especially for transcription factors which execute their biological function within the cell nucleus, such regulated subcellular localization provides an attractive way to control their activity (Whiteside and Goodbourn, 1993) . This indeed has been demonstrated for several key players of signal transduction cascades (Cartwright and Helin, 2000; Knauer et al., 2005a) .
Although TFIIA was described as a nuclear protein, consistent with its biological function as a transcriptional regulator (Hoiby et al., 2007) , we here show its localization is not restricted to this cellular compartment. A highly efficient NES between aa 21 and 30 enables it to also reside in the cytoplasm, counteracting its nuclear localization and thus, transcriptional activity together with proteolytic cleavage by Taspase 1. Thus, by regulating the nuclear availability of TFIIA, the Crm1/Taspase 1-axis establishes a fine-tuning mechanism for transcriptional regulation of TFIIA target genes.
Results

TFIIA shows a dynamic subcellular localization regulated by cooperating mechanisms
To dissect the mechanisms regulating TFIIA's intracellular localization, we cloned the TFIIA open reading frame (ORF) from total RNA isolated from head and neck tumor tissue. Sequence analysis revealed an ORF identical to the wt sequence initially described (Hsieh et al., 2003) . Interestingly, transient ectopic expression of the precursor as a TFIIA-green fluorescent protein (GFP) fusion initially revealed a predominant cytoplasmic localization in live interphase A431, HeLa, and RKO cells ( Figure 1A) , which was in sharp contrast to the previously suspected nuclear localization. With a molecular weight of more than 60 kDa, the fusion protein is still within the upper size limit for passive diffusion through the nuclear pores. Nevertheless, as active transport processes can be regulated more precisely and efficiently, larger proteins often rather rely on active nuclear transport (Fetz et al., 2009b) . To determine whether such active processes might contribute to the subcellular localization differences observed, cells transiently expressing TFIIA-GFP were treated with the nuclear export inhibitor leptomycin B (LMB) specifically binding to the export receptor Crm1 and preventing its interaction with leucine-rich export signals in a signal-unselective manner. Indeed, this resulted in nuclear accumulation of the fusion protein ( Figure 1A) . Interestingly, the initially observed cytoplasmic localization shifts towards the nucleus in stably expressing A431 cells even without LMB treatment ( Figure 1B) . However, as LMB-induced translocation was less prominent than nuclear accumulation elicited by stable expression, the latter might additionally involve another molecular mechanism. Of note, we also tried to establish stable TFIIA-GFP-expressing HeLa and RKO cells, but expression was lost ∼2 weeks after initial transfection and G418 selection. Especially for HeLa cells, this is a well-known phenomenon, even when the respective insert is not cytotoxic. As for the TFIIA precursor posttranslational cleavage in two subunits by Taspase 1 was described, we mutated residues required for Taspase 1 processing ( 272 QVDGTGD 278 to 272 QVAATGD 278 ), resulting in the uncleavable fusion construct TFIIA unclev -GFP. Transient expression also revealed a cytoplasmic protein localization, which was still responsive to LMB treatment ( Figure 1C) . In stably transfected cell lines, nuclear accumulation of the uncleavable fusion protein was indeed not as pronounced as in cells stably expressing wt TFIIA-GFP, and the protein was still detectable in the cytoplasm ( Figure 1D ). Western blot analyses demonstrated that the cleavage site mutation indeed prevented processing by ectopically expressed, active Taspase 1 ( Figure 1E ). Differences in subcellular localization of wt and uncleavable TFIIA-GFP, also between transiently and stably expressing cell lines and following export inhibition could be independently quantified by automated microscopy and measurement of cytoplasmic and nuclear fluorescent intensity ratios ( Figure 1F and Supplementary Figure S1 ). Briefly, automated analysis of the molecular translocation assay was performed using the Cellomics ArrayScan ® VTI Imaging Platform. Staining with Hoechst 33342 allowed defining the circular mask representing the cell nucleus (CIRC), which was dilated to achieve the ambient cytoplasmic GFP mask (RING, Figure 1F ). The switch from transient transfection to stable expression is a rather gradual transition over longer periods of time. Therefore, we also performed a detailed analysis of TFIIA relocalization kinetics in cell lines of different origin (A431, HeLa, HeLa Kyoto, and U2OS). This revealed an outright nuclear accumulation of previously cytoplasmic TFIIA-GFP already 48 h after transfection (Supplementary Figure S2A ) irrespective of the cell line. Of note, this could neither be further enhanced by extending protein expression to 72 h nor by mutation of the TFIIA cleavage site (Supplementary Figure S2B) .
TFIIA contains a highly efficient evolutionary conserved NES Nuclear accumulation of TFIIA-GFP in response to LMB treatment already suggested the presence of an active, Crm1-dependent NES. Thus, we performed an in silico analysis to screen for leucine-rich NES, indeed identifying a hydrophobic region of the classical Φ- Figure 2A and Supplementary Figure S3A) . Notably, this Nterminal 3-2-1 type NES motif, classified according to the number of aa between the hydrophobic residues, is resembling the NES of the well-known protein kinase inhibitor (PKI), not only with regard to the primary aa sequence but also in terms of its 3D structure. Co-crystallization of TFIIA's 58 N-terminal residues with TBP and DNA (PDB 1NVP) (Bleichenbacher et al., 2003) demonstrate an α-helical conformation of the NES with the side chains of the critical hydrophobic aa pointing outwards (Supplementary Figure S3B) , typical for PKI-like signals (Guttler et al., 2010) .
The remarkably high evolutionary conservation concerning sequence and in most cases also position of the NES at the N-terminus in known TFIIA homologs (Supplementary Figure S3C ) moreover considerably suggests a functional relevance. On the contrary, bioinformatic analyses employing the consensus sequence for Importindependent NLS, regions of clustered basic aa residues, did not indicate the presence of such a signal in TFIIA (Supplementary Figure S4A ). To experimentally verify the activity of the NES, we first expressed the different TFIIA subunits as well as a truncated isoform of TFIIA (isoform 2) as GFP fusions ( Figure 2A and B). Indeed, only one fusion protein containing the putative NES, namely TFIIA α -GFP, shows an exclusively cytoplasmic localization directly after transfection and accumulates in the nucleus following LMB treatment ( Figure 2B ). The C-terminal subunit TFIIA β -GFP as well as the N-terminally truncated TFIIA isoform2 -GFP are more homogenously distributed with an only marginal nuclear accumulation, and do not respond to LMB ( Figure 2B ). The alternative transcript TFIIA isoform2 is endogenously lacking the first 39 aa and thus the potential NES ( Figure 2A ). Of note, following its cellular distribution over time does not reveal a significant increase in nuclear localization (Supplementary Figure S5A) . Taken together, this rather indicates for passive diffusion of TFIIA in the absence of the NES, despite the above mentioned molecular weight of the GFP fusion protein. Passive diffusion is even more likely due to the less molecular weight of the shorter isoform. Taken together, our data additionally argue against the presence of an active NLS, which should result in a rather rapid and exclusively nuclear accumulation. To finally prove that the predicted sequence indeed functions as a bona fide NES mediating active subcellular transport, we performed microinjection experiments of recombinant transport substrates containing the aforementioned sequence. Integration of the N-terminal 40 aa residues of TFIIA 
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, mutated aa underlined) does not influence initial cytoplasmic localization or LMB responsiveness (C). Although nuclear accumulation of the uncleavable fusion protein can be observed in stable transfectants, with a significant amount still residing in the cytoplasm it is not as pronounced as in cells stably expressing wt TFIIA protein (D). Scale bar, 10 μm. (E) Immunoblot analysis of Taspase 1 co-transfectants demonstrated proteolytic cleavage of TFIIA-GFP (cl, cleaved), but not of the respective uncleavable mutant. The ectopically expressed full-length (fl) Taspase 1 is autoprocessed into its two active subunits, with only the α-subunit being recognized by the respective antibody. GapDH served as the loading control. (F) Confirmation of subcellular TFIIA localization by automated microscopic quantification in transient HeLa (24 h) and stable A431 transfectants before and 3 h after LMB treatment using the Cellomics ArrayScan ® VTI. Cytoplasmic and nuclear fluorescent intensity ratios were calculated from the circular mask representing the cell nucleus (CIRC), which was dilated to achieve the ambient cytoplasmic mask (RING). Regarding the resulting average intensity differences in the GFP channel (CircRingAvgIntenDiffCh2), negative values equal a cytoplasmic, positive values a nuclear localization. DMSO was used as negative control. ; hydrophobic aa following the NES consensus sequence in bold), the Taspase 1 cleavage site (
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) as well as corresponding α-and β-subunits are indicated. Isoform 1 comprises 376 aa, whereas isoform 2 lacks the first 39 aa and thus the potential NES. Sizes are not drawn to scale. (B) Localization of C-terminal GFP fusions of TFIIA variants in live HeLa transfectants. Whereas the α-subunit is exclusively cytoplasmic and accumulates in the nucleus after export inhibition by LMB, the β-subunit and TFIIA isoform 2 show a more homogenously distribution to nuclear localization and do not respond to LMB treatment. (C) Indicated recombinant GST-TFIIA-GFP substrates were microinjected into the nucleus of Vero cells, and nuclear export in live cells were documented by fluorescence microscopy at indicated time points. Indeed, the N-terminal 40 aa residues of TFIIA mediated very fast and efficient export into the cytoplasm following nuclear injection of the fluorescent substrate, whereas mutation of two essential hydrophobic aa residues into alanine within the NES consensus (
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; hydrophobic aa of the NES consensus in bold, mutated aa underlined) prevented nuclear export for at least 6 h. Approximately 50 cells were injected, and representative examples are shown. (D) Localization of transiently transfected wt TFIIA-or export-deficient TFIIA NESmut -GFP fusions in live Hela transfectants. Inactivation of the NES indeed resulted in a homogenous cellular distribution of TFIIA directly after transfection, which was not altered by treatment with LMB. Scale bar, 10 μm; dashed lines mark cell boundaries obtained from the corresponding phase contrast images. (E) GST-TFIIA-GFP and GST-TFIIA 1-40 -GFP efficiently interacted with the in vitro translated transport receptor Crm1-HA. Mutation of the export signal (GST-TFIIA 1-40NESmut -GFP) as well as co-incubation with the Crm1 inhibitor LMB almost completely abolished binding. Immunoprecipitated proteins were identified by immunoblot using the indicated tag-specific antibodies. Input represents the total amount of cell lysate added to the IP; relative signal intensities were quantified by densitometric analysis using ImageJ and indicated by numbers.
into a glutathione S-transferase (GST)-GFP fusion protein demonstrated very fast and efficient export into the cytoplasm following nuclear injection of the fluorescent substrate (t = 12 min) ( Figure 2C) . Worthy of mention, this export kinetics even exceed the transport rate of the already very fast PKI-NES (t = 40 min, Supplementary Figure S3D ). Mutation of two essential hydrophobic aa residues in the export signal (TFIIA 1-40NESmut ) prevented nuclear export for at least 6 h ( Figure 2C ). Of note, the recombinant substrate without any sequence integration, GST-GFP, remained at the site of injection for at least 18 h demonstrating that our results are not flawed by passive diffusion (Supplementary Figure S3E) . To finally verify the activity of the NES also in the physiological context of the full-length protein, we introduced the mutations, which inactivated the export signal in the recombinant substrate ( Figure 2C ), into our eukaryotic TFIIA expression constructs by site-directed mutagenesis (TFIIA NESmut ). Ectopic expression studies of GFP fusions as well as untagged constructs demonstrated that inactivation of the NES resulted in a homogenous cellular distribution of TFIIA directly after transfection, which was neither altered by prolonged transient expression (Supplementary Figure S5B ) nor by treatment with LMB ( Figure 2D) , thereby excluding the presence of additional export signals.
To demonstrate that TFIIA's nuclear export is mediated via a direct interaction with the export receptor Crm1, we performed cell-free pulldown experiments. Co-incubation of in vitro translated Crm1-HA with the respective recombinant cargoes revealed that GST-TFIIA-GFP and GST-TFIIA 1-40 -GFP, but not a mutant variant thereof (GST-TFIIA 1-40NESmut -GFP), efficiently interacted with the transport receptor ( Figure 2E) . Moreover, co-incubation with the Crm1-inhibitor LMB prevented binding of the wt transcription factor also in vitro. Collectively, these experiments unambiguously identified a leucine-rich NES in TFIIA directly interacting with Crm1.
Taspase 1 cleavage counteracts TF2A nuclear export As mutation of the Taspase 1 cleavage site at least partially counteracted nuclear enrichment of TFIIA-GFP in stable cell lines (Figure 1) , we sought to comprehensively elucidate the dependence of TFIIA's cellular localization on its proteolytic processing. Therefore, we additionally introduced an N-terminal myc-tag to our TFIIA-GFP constructs to undoubtedly localize both subunits ( Figure 3A) . Indeed, transient co-expression of myc-TFIIA-GFP with the fluorescently labeled active protease resulted in a nuclear accumulation of both subunits after successful cleavage ( Figure 3B and D) . In contrast, the catalytically inactive mutant (Tasp T234V ) did not alter TFIIA's predominant cytoplasmic localization ( Figure 3C ), and both fluorescent signals co-localize, representing the uncleaved, full-length construct as assessed by immunoblot analysis ( Figure 3D ). As a control, co-expression of Taspase 1 or its inactive mutant did not affect the cytoplasmic localization of the non-cleavable mutant myc-TFIIA uncleav -GFP ( Figure 3B and C). Interestingly, combination of both mutations in the cleavage site and the NES (TFIIA uncleavNESmut ) induces nuclear accumulation comparable to the single NES mutation, also not augmented by co-expression of active nor inactive Tapsase1 or treatment with LMB ( Figure 3B , C, E). Prolonged expression in different cell lines as well results in a marginal to more prominent nuclear accumulation dependent on the respective cell line (Supplementary Figure S5C) Of note, all results could be verified with the respective GFP-tagged TFIIA constructs lacking the N-terminal myc-tag (Supplementary Figure S6) . In order to finally prove the absence of active nuclear import processes, we moreover equipped our TFIIA constructs with an N-terminal GST tag prohibiting passive diffusion (Supplementary Figure S4B) . This results in a fusion protein of ∼88 kDa, showing a more or less exclusively cytoplasmic localization (Supplementary Figure S4C) . Notably, all the NES-deficient mutants, TFIIA NESmut -GFP, TFIIA uncleavNESmut -GFP, and isoform 2, are now cytoplasmically localized, indicating deficiency in active nuclear access. In the absence of nuclear export, only active import signals could result in a nuclear relocalization of the diffusion-incompetent GST fusion constructs.
TFIIA's regulated subcellular localization modulates binding to TBP and vice versa To support transcription, both uncleaved αβ and cleaved α-and β-subunits interact with the TFIIA γ-subunit and also with TBP. To thus investigate the effect of this important multifactorial crosstalk on subcellular localization, we made use of different fluorescently tagged TFIIA subunits (Supplementary Figure S7A and B). As already mentioned above, GFP-tagged versions of the α-subunit exclusively localize to the cytoplasm, whereas the β-subunit shows a more homogenous distribution and nuclear accumulation directly after transient transfection ( Figure 2B) . Also, another fluorescently tagged variant, TFIIAα-mCherry, stably localizes to the cytoplasm, and localization of the subunits was again not altered by prolonged transient expression (Supplementary Figure S7C) . Whereas co-expression of the separated subunits TFIIAα-mCherry and TFIIAβ-GFP does not change their individual subcellular localization (Supplementary Figure S7D) , transient co-transfection of homogenously distributed TFIIAγ-mCherry with wt cytoplasmic TFIIA-GFP results in a strong nuclear accumulation of both proteins (Supplementary Figure S7E and F). With regards to TBP, nuclear variants of TFIIA efficiently colocalize with nuclear TBP-mCherry and likewise with endogenous TBP in contract to cytoplasmic wt TFIIA-GFP and the respective uncleavable mutant TFIIA uncleav -GFP following transient transfection ( Figure 4A and B, Supplementary Figure S8A and B) . Biochemical analyses demonstrated that the non-cleavable and export-deficient mutant TFIIA uncleavNESmut -GFP most efficiently interacts with endogenous TBP, thus confirming that interaction of TFIIA with TBP is cooperatively enhanced by inhibition of TFIIA cleavage and timely enhanced nuclear co-localization ( Figure 4C and Supplementary Figure S8C) . Regions mediating TBP binding were assigned to the C-terminal β-barrel domain present in the TFIIA β-subunit, more precisely the C-terminal Trp376 and a basic cluster around Arg344 (Supplementary Figure S9A) . However, mutation of the C-terminal tryptophan W376 alone does not change subcellular localization or interfere with time-dependent nuclear relocalization of TFIIA, independently of additional cleavage site inactivation (Supplementary Figure S9B) . In contrast, deleting the major part of the C-terminal β-barrel domain (aa 342-376) leads to a cytoplasmic localization of TFIIA stable over time (Supplementary Figure S9B) . Biochemical analyses revealed that TFIIA W376A -GFP still efficiently interacts with endogenous TBP, in contrast to the deletion mutant TFIIA Δ342-376 -GFP, lacking the TBP binding region. This, in turn leads to a cytoplasmic localization of TFIIA, and seems to be advantageous for cell growth by directly linking hindrance of nuclear TFIIA enrichment to impaired TBP binding. To functionally evaluate the effects of the different mutations, we performed cell proliferation assays with A431 cells stably expressing the TFIIA-GFP variants. Indeed, in contrast to impaired TBP binding, export deficiency and restriction of proteolytic cleavage cooperatively compromise cancer cell proliferation ( Figure 4D) . Mutation of the NES or the cleavage site (CS) led to a proliferation disadvantage of cells stably overexpressing the respective mutant compared to wt TFIIA-GFP. The effect was even more prominent and highly significant when both mutations were combined (TFIIA uncleavNESmut -GFP). In contrast, deletion of the C-terminal TBP-binding interface (TFIIA Δ342-376 -GFP) rather seems advantageous for cancer cell growth, regardless of proteolytic processing. It has been demonstrated that uncleaved TFIIAαβ in conjunction with TFIIAγ and TBP is able to induce cell cycle-specific transcription (Hoiby et al., 2007) . This involves the cdnk2a gene locus encoding for the cell cycle regulators p16 
278
; mutated aa underlined). Introducing the previously described NES consensus mutation (
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; hydrophobic aa of the NES consensus in bold, mutated aa underlined) into the full-length constructs resulted in a nuclear accumulation of the resulting proteins myc-TFIIA NESmut -GFP and myc-TFIIA uncleavNESmut -GFP irrespective of Taspase 1 activity or LMB treatment. Scale bar, 10 μm. (E) Immunoblot analysis of Taspase 1 co-transfectants demonstrated proteolytic cleavage of myc-TFIIA-GFP and myc-TFIIA NESmut -GFP (cl, cleaved), but not of the respective uncleavable mutants 24 h after transfection. The ectopically expressed fulllength (fl) wt Taspase 1, but not the catalytically inactive mutant is autoprocessed in its two active subunits, with only the α-subunit being recognized by the respective α-Taspase antibody. Of note, the α-GFP antibody also detected the related blue fluorescent protein and thus full-length Tasp-BFP and the β-subunit containing the fusion tag. overexpressed TBP-mCherry 24 h after transfection in live (A) and with endogenous TBP in fixed (B) HeLa Kyoto cells. In contrast to transiently transfected, cytoplasmic wt TFIIA-GFP and the respective uncleavable mutant TFIIA uncleav -GFP, nuclear variants of TFIIA efficiently co-localize with likewise nuclear TBP. Scale bar, 10 μm. (C) Interaction of TFIIA with TBP is cooperatively enhanced by inhibition of TFIIA cleavage and enhanced nuclear co-localization. Immunoprecipitations (IPs) were carried out in lysates of 293T cells transfected with the indicated constructs 24 h after transfection using an α-TBP antibody. Precipitated proteins were separated by SDS-polyacrylamide gel electrophoresis and identified by immunoblot using the indicated antibodies, demonstrating that the non-cleavable and export-deficient mutant TFIIA uncleavNESmut -GFP most efficiently interacts with endogenous TBP. Input equals 3% of cell lysate added to the immunoprecipitate; GapDH served as the loading control. Relative signal intensities were quantified by densitometric analysis using ImageJ and indicated by numbers. (D) Restriction of proteolytic cleavage and export deficiency cooperatively compromise cancer cell proliferation, but not hinderance of TBP binding capacity that even mediates minor growth advantage. A431 cells stably expressing the indicated expression constructs were seeded 24 h before measurement of ATP content indicative for cell viability were conducted. Relative light units (RLU) were measured at 48 h and 96 h after seeding and plotted as fold proliferation relative to the 24 h time point. Single mutations of the NES or the cleavage performed reporter gene studies ( Figure 4E) . Following cotransfection of TFIIA variants with a firefly luciferase reporter vector containing the wt p16INK4a 5′-UTR, gene induction in 293T cells was measured with a dual luciferase assay using renilla luciferase for normalization. Empty pGL3 basic served as negative control. In fact, wt TFIIA efficiently induced transcription of the p16 INK reporter, and this effect was reinforced by enhanced nuclear localization as implemented in the respective engineered TFIIA variants. Especially the combination of the nonfunctional NES with the compromised Taspase 1 cleavage site resulted in a significant increase in reporter gene activation, which was less pronounced in variants harboring only the respective single mutations. Predictably, deletion of the C-terminal TBP-binding site in TFIIA ablates transcriptional activation, again regardless of integrity of the protease cleavage site.
Discussion
The initiation of gene transcription by RNA polymerase II is governed by the timely and spatially regulated assembly of GTFs that form the PIC in gene promoter regions (Freiman, 2013; Kandiah et al., 2014) . In particular, TFIIA plays an important role in PIC assembly in response to some transcriptional activators, e.g. enhancing the affinity of TBP binding to its target site (Hoiby et al., 2007) . TFIIA is as well essential for basal transcription with TFIID by stabilizing complexes with DNA and counteracting the inhibitory effects of negative cofactors (Takeda et al., 2015) , however the exact molecular mechanisms underlying its complex spatiotemporal regulation in different developmental stages are still not completely understood. Also, whether and to what extent Taspase 1-mediated processing of TFIIA modulates its functions, in particular with regard to TFIID and TBP activity is still a matter of debate. Very recent structural studies using cryo-electron microscopy could provide valuable insights into PIC assembly, transcription promoter as well as DNA opening Louder et al., 2016; Plaschka et al., 2016) . However, since the first crystal structure of human TFIIA was released over than 10 years ago (Bleichenbacher et al., 2003) , with more than 200 aa still missing, large central parts of the protein including the Taspase 1 cleavage site remain blank spots on the map of transcription. Contrariwise, this novel studies assign rather important roles to TFIIA in fine-tuning of timing and rate of PIC assembly, e.g. by timely bridging of the TBP-TATA complex with lobe B of TFIID, competing for DNA binding with TAFs (Louder et al., 2016 ) and regulating DNA positioning over the Pol II cleft (Plaschka et al., 2016) . Indeed, Taspase 1 processing of TFIIA affects the conformation of TFIID/TFIIA promoter complexes (Malecova et al., 2015) . It thus enables assembly with TFIID and the TBP-related factor TRF2, and thereby transcription of, e.g. genes involved in spermiogenesis and is moreover indispensable for subsequent proteasome-mediated degradation (Hoiby et al., 2007) . As in contrast binding to classical TAFs might enable uncleaved TFIIAαβ/γ to induce bulk transcription during development, Taspase 1 cleavage is providing the clue to switching between general and very specific transcriptional patterns and allows pivotal developmental fine-tuning. As mentioned before, regulated subcellular localization indeed provides an attractive way to control transcription factor activity, which is constricted to the cell nucleus (Whiteside and Goodbourn, 1993; Cartwright and Helin, 2000; Knauer et al., 2005a) . Controlling subcellular distribution of Taspase 1 via the Crm1 axis might thus serve as an upstream checkpoint to ensure adequate nuclear TFIIAαβ/γ and TFIIAα/β/γ concentrations for transcription of genes relevant for the respective status of the cell like its developmental state or cell cycle phase. It would be even tempting to speculate that the NES could safeguard the nuclear presence of TFIIA only in relevant phases of the cell cycle to promote transcription of cell cyclespecific regulators. Another possibility of transcription factor regulation is the length of time that transcription factors remain (active) in the nucleus (Hogan and Rao, 1999) . Indeed, giving credence to most databases the vast majority of transcription factors is residing inside the nucleus, neglecting dynamically regulated subcellular localization as means of activity regulation. There is a plethora of examples for transcriptional activators not only bearing NLS, but also NES, e.g. the signal transducer and activator of transcription (STAT) proteins (Krämer et al., , 2009 , homeobox developmental regulators (Knauer et al., 2005a) or the prominent tumor suppressor p53 (Brandl et al., 2012) . Albeit initially described as mainly nuclear localized by the UniProtKB/Swiss-Prot database [P52655-TF2AA_HUMAN], TFIIA was assigned to the cytoplasmic compartment by gene ontology [GO:0005737] , an inconsistency to be urgently resolved. Surprisingly at first sight, freshly transfected, unprocessed TFIIA localized predominantly to the cytoplasm in different cell lines. This initial localization was counteracted by treatment with the nuclear export inhibitor LMB, but unaffected by genetic inactivation of the cleavage site within TFIIA, suggesting accessibility of the respective aa residues in the uncleaved, fulllength protein. We then applied deletion mutagenesis in combination with microinjection, in vitro binding assays and ectopic site (CS) led to a proliferation disadvantage of stably expressing cells compared to wt TFIIA-GFP-bearing cells, which was significantly enhanced by their combination (TFIIA uncleavNESmut -GFP). However, deletion of the C-terminal TBP-binding interface (TFIIA Δ342-376 -GFP) was rather advantageous for cancer cell growth, regardless of additional CS inactivation (TFIIA uncleavΔ342-376 -GFP). Bars are means of five replicates with standard deviations. Results of one representative experiment are shown (n = 3, * P < 0.005). (E) Impairment of cleavage and nuclear export result in increased activation of the cell cycle regulator p16 INK , counteracted by genetic ablation of TBP binding. 293T cells were seeded 24 h before co-transfection with either pGL3 basic or pGL3 basic-wt p16INK4a 5′-UTR reporter, pRLSV40, and the respective TFIIA variant or pc3-GFP as negative control. RLU were measured 24 h later, normalized for transfection efficiency, and plotted as foldinduction relative to the corresponding empty pGL3 basic vector co-transfection control for indicated TFIIA variants or pc3-GFP. Bars are means of triplicates with standard deviations. Results of one representative experiment are shown (n = 3, *P < 0.005). ) in TFIIA. This signal not only mediated very fast export kinetics of less than 15 min following nuclear injection, but was moreover evolutionarily highly conserved NES in mammalian TFIIA proteins, indicative for a pivotal functionality. Indeed, the only mutation in this TFIIA region according to human cancer mutation databases (http://cancer.sanger.ac.uk/cosmic/; http://www. cbioportal.org/) is a conservative missense mutation exchanging Leu30 to Val (c.88 C > G, p.L30V), not altering the hydrophobicity in the NES consensus sequence. Genetic inactivation of the NES by mutation of critical, highly conserved hydrophobic residues directly triggered its nuclear accumulation. Unexpectedly, although propagated we could not verify the existence of an active nuclear import signal (NIS). However, the TFIIA precursor with a molecular mass of 55 kDa could theoretically enter the nuclear compartment via passive diffusion, likewise its two subunits with 35 and 19 kDa, respectively, the latter also as GFP fusions of 61 and 45 kDa. In fact, even TFIIA-GFP with ∼80 kDa is able to access to the nuclear compartment as revealed by the export-deficient NES mutant. This molecular weight is clearly exceeding the passive diffusion limit of ∼60 kDa (Yoneda, 2000) , but could be explained by structural peculiarities. The different regions of TFIIA corresponding to the later subunits, or at least the parts already structurally resolved rather appear as separated globular domains. Those could pass through the nuclear pore one after the other, similar to tandem fusions of GFP barrels, where only three separate units are occluding passive NPC passage (Rosorius et al., 1999) . Interestingly, the existence of only a NES with lack of active import although previously speculated resembles the tumor-relevant protein survivin, as well small enough for passive nuclear entry (Knauer et al., , 2007b . Here, molecular mass with 16.5 kDa is of course more alike the small β-subunit of TFIIA. However, only microinjection could unambiguously exclude the possibility of active import, again underlining the absolute necessity of experimental verification of database predictions. Nevertheless, import of TFIIA might be mediated via interaction with other proteins capable of nuclear import. Indeed, there is evidence for other proteins to be shuttled inside different cellular compartments even without harboring nucleocytoplasmic transport signals by hitching a hike on other shuttle proteins upon interaction. This was e.g. demonstrated by our group for the nuclear export of Taspase 1 itself, making use of the NES of its interaction partner NPM-1 (Bier et al., 2011a) . Therefore, we analyzed the most important interactions partners of TFIIA for the presence of potential nuclear import sequences (Supplementary Table S2 ). For TFIIAγ, which has a molecular weight of 12 kDa, no NLS and thus no active nuclear import has been described so far. The lack of an import signal could be confirmed by bioinformatic analyses employing the consensus sequence for Importin-dependent NLS, regions of clustered basic aa residues, in analogy to TFIIA (Supplementary Figure S3A) . Also, analysis of the TBP aa sequence revealed no known NLS (Pemberton et al., 1999) . Here, nuclear import is mediated by a new karyopherin (importin) family member, Kap114p in yeast. The human isoform with its 38 kDa shows 77% identity to yeast TBP, with an especially high conservation of the C-terminus where most basic clusters reside. Thus, it seems rather unlikely that TBP is capable of active nuclear import and thus of backpacking TFIIAαβ to mediate its access the nucleus. Another important interaction partner of TFIIA, p300, with 264 kDa a rather large protein, indeed was shown to contain a bipartite NLS highly conserved in mammals (Yuan and Gambee, 2000; Yuan and Giordano, 2002) , and bioinformatic analyses even suggest the presence of more potential import signals (Supplementary Table S2 ). Nevertheless, a protein complex consisting of p300 and TFIIA would weigh more than 300 kDa, and the possibility of active nuclear transport might largely depend on the concrete structural arrangement and thus bulkiness of the protein assembly. Last but not least, its molecular weight of 21 kDa would allow TRF2 to access the nucleus via passive diffusion, and so far, no active nuclear import was described. However, bioinformatic analyses revealed a potential NLS in its N-terminal part with rather high probability. Taken together, one could indeed speculate that nuclear import of TFIIA might be mediated via binding to partner proteins that are actively imported, but still has to be proven experimentally. With respect to proteolytic processing, overexpression of Taspase 1 but not of catalytically inactive variants enhanced TFIIA's direct nuclear accumulation, and non-cleavable TFIIA mutants revealed an enhanced and elongated cytoplasmic localization. This leads us to the conclusion that processing of TFIIA by Taspase 1 might mask the NES, albeit lacking support by the incomplete structural data available so far. Possible scenarios include conformational changes in the α-subunit, which would shift the relative position of the subunit assembly and in turn lead to a complete masking of the NES. The latter could as well be a direct result of binding to TBP. Assuming the NES minimizes presence of TFIIA inside the nucleus at unwanted time points and in turn enables an accurately fitting, timely supply synchronized with the cellular necessities, irreversible proteolytic loss of the signal could disturb this phase-dependent regulatory mechanism of nuclear TFIIA concentration. However, Taspase 1-mediated cleavage could rather prime TFIIA for transcriptional activity not depending on the cell cycle phase but requiring a high Taspase 1 level for specific developmental gene transcription. On the other hand, long-term expression of TFIIA leads to its nuclear accumulation irrespective of cleavage, which could rely at least partially on the timely formation of tight protein interactions as they appear, e.g. in the large PIC multi-subunit assembly, with the respective endogenous partner proteins expressed at stoichiometric amounts.
Taken together, this would indicate for a cooperative TFIIA fine-tuning mechanism comprised of active transport, proteolysis and dynamic protein interaction ( Figure 5 ). More precisely, TFIIA is regulated by a 'cleave-and-run' switch involving interaction with the nuclear export receptor Crm1/Exportin-1 and subsequent proteolytic cleavage by Taspase 1, enabling specific protein interaction with other transcriptional regulators. Besides its involvement in the initiation of general bulk transcription (Hoiby et al., 2007) , TFIIA is modulating cell cycle-and embryospecific transcription, e.g. on the cdnk2a gene locus encoding for the cell cycle regulators p16 INK , p19 ARF , and p21 CIP (Takeda et al., 2015) . This set of inhibitors halt cell cycle progression by different means in G1 and S phase, and thus are indispensable for regulated cell proliferation per se and in particular when it comes to tumor development and progression. Indeed, interaction of TFIIA with the TBP, a prerequisite for transcriptional activation, is cooperatively enhanced by inhibition of TFIIA cleavage and timely enhanced nuclear co-localization, finally resulting in impaired cell proliferation. Relying on the crystal structure (Tan et al., 1996) , TBP binding should include the C-terminal β-barrel of TFIIA, comprising aa 334 to 376, especially residues Arg344 and Trp376 enabling direct contact with TBP , which halt cell cycle progression by different means in G1 and S phase. This interaction and consequent inhibition of cancer cell proliferation are significantly increased by enforced nuclear localization of uncleavable TFIIA for instance. Of note, binding to classical TAFs (light gray) might enable uncleaved TFIIAαβ/γ to induce bulk transcription during development; however, there might be a competition for TBP binding. In contrast, cleavage by Taspase 1 into TFIIAα/β/γ enables assembly with the TBP-related factor TRF2 and cnosequent transcription of genes involved in spermiogenesis, for instance, and is moreover indispensable for subsequent proteasome-mediated degradation. As enforced nuclear localization in conjunction with proteolytic cleavage counteracts TBP binding, the different means of TFIIA regulation synergistically contribute to its distinct gene regulatory functions in differentiation. Notably, proteolytic processing of TFIIA by Taspase 1, which can be counteracted by the TBP-like protein TLP, might indeed prohibit accessibility of the NES for its cognate receptor Crm1, thereby as well promoting nuclear localization and transcriptional activity. Conclusions based on functional investigations not part of this study are designated by lesser opacity or in light gray. and besides Arg344 also Lys341 and Lys346 mediating DNA binding. Mutation of the C-terminal tryptophan was not sufficient for genetic ablation of TBP binding, only deletion of the majority of the TFIIA β-barrel (aa 342 to 376). In addition, this TFIIA variant showed a stable, long-term cytoplasmic localization and no nuclear relocalization irrespective of proteolytic cleavage, again underlining the contribution of protein interactions to the complex regulation of TFIIA localization and function. On the molecular level, reporter gene studies revealed a transcriptional activation of the cell cycle regulator p16 INK , which was most prominent in variants with genetically enforced nuclear localization in conjunction with hindered proteolytic cleavage. p16 INK , also known as cyclin dependent kinase inhibitor 2A,
interacts with CDK4 and CDK6, inhibiting their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein, finally hindering entry into the S phase and thus considered a tumor suppressor (LaPak and Burd, 2014) . Indeed, enhanced nuclear localization achieved by a non-functional NES, in particular combined with a mutated cleavage site resulted in a significant increase in reporter gene activation compared to wt TFIIA, again dependent on TBP binding. Although it was recently suggested that cleaved and noncleaved TFIIA are equally capable of TBP binding and the primary function of Taspasemediated proteolysis is the regulation of cellular TFIIA levels (Takeda et al., 2015) , our data indicate for a far more complex situation. We could attest uncleaved TFIIA a differential TBP binding affinity, dependent on the context of the current protein interaction spectrum. In the wt context, binding was marginally lower, but in combination with abolished export ability, interaction with TBP was heavily increased which in turn resulted in altered transcriptional activation and finally significantly impeded cell proliferation. Collectively, we here describe a hitherto unknown mechanism how the different means of TFIIA regulation-proteolysis, dynamic protein interaction, and distinct subcellular localizationsynergistically contribute to fine-tuning of target gene transcription and thus its temporally modulated gene regulatory functions in cellular and organismic differentiation.
Materials and methods
Antibodies (Ab), reagents, and compounds
Ab used: α-GAPDH (sc-47724; Santa Cruz Biotechnology); α-GFP (sc-8334; Santa Cruz Biotechnology); α-Taspase 1 (sc-85945; Santa Cruz Biotechnology); α-TBP (ab818; Abcam); α-TFIIA-β (sc-5315; Santa Cruz Biotechnology); α-Myc-tag (2272; NEB); α-HA Clone 16B12 (MMS-101R; Covance). Appropriate HRP-, Alexa 350-or Alexa 594-conjugated secondary antibodies (Santa Cruz Biotechnology; Life Technologies) were used. Reagents were from Sigma Aldrich unless stated otherwise. Cells were treated with the export inhibitor leptomycin B (LMB) (10 nM, 3 h) as described (Knauer et al., 2010) .
Cell culture, microscopy fluorescence imaging of cells and computer-assisted microinjection Cell lines used in the study were maintained and transfected using Lipofectamine ® 2000 (Thermo Fisher Scientific) as described (Fetz et al., 2009a; Knauer et al., 2010) . Stably expressing A431 cells were established by G418 (800 μg/ml) selection, and fluorescence activated cell sorting as reported (Fetz et al., 2009b) . Twelve-bit black and white images were captured using a digital Axiocam CCD camera (Carl Zeiss). Quantitation, image analysis and presentation were performed as described (Knauer et al., 2005b; Habtemichael et al., 2010a) . Purification and microinjection of recombinant GST-GFP transport substrates were performed as described in detail (Knauer et al., 2005a) .
Cellomics ArrayScan ® VTI-based HCS
Automated analysis of the molecular translocation assay was performed using the Cellomics ArrayScan ® VTI Imaging Platform (Thermo Fisher Scientific Inc.). Cells were seeded with an electronic multichannel pipette (Eppendorf) into black-walled 96-well thin bottom Greiner μclear ® plates (Greiner) and incubated at 37°C, 5% CO 2 and 95% humidity. Cells were transfected, and the export inhibitor leptomycin B (LMB) (10 nM, 3 h) was added 4 h later. For each experiment two wells were drug treated, and each experiment was performed in duplicates. DMSO was used as a control. 48 h later, cells were fixed by the addition of 50 μl 4% PFA, and nuclei were stained by addition of Hoechst 33342 at a final concentration of 40 μM for 10 min. After a final wash with PBS, 50 μl PBS were left in each well and the plates were sealed and stored at 4°C. Images were acquired and analyzed on the Cellomics ArrayScan ® VTI Imaging Platform as described (Fetz et al., 2009b) . Briefly, binary image masks were created for GFP, mCherry and Hoechst 33342 positive staining to define regions of interest (ROI) for analysis. For this purpose, we applied a median filter (3 × 3 pixel radius) to remove noise and to approximate the distribution of staining intensity to a median value. Automatic thresholding using the Isodata algorithm was used to convert the image to a binary mask that included all fluorescence data above background (Fetz et al., 2009b) . The Hoechst 33342 staining (channel 1) mask was used to define the nuclear ROI. Subsequently, the Hoechst 33342 mask was subtracted from the GFP mask (channel 2) to create a staining mask defining the cytoplasmic ROI. Scans were performed sequentially with settings to give sub-saturating fluorescence intensity, and a minimum of 400 valid objects per well was recorded.
Plasmids
Eukaryotic expression constructs encoding wt TFIIA, Crm1, Taspase 1 and its catalytically inactive mutant Taspase T234V , untagged or as fusions with autofluorescent proteins (GFP, BFP, mCherry) or short expression tags (myc, HA) were described (Bier et al., 2011b) . TFIIA subunits, isoform2, and TBP were amplified from full-length TFIIA or TBP cDNA and cloned into pcDNA3.1-GFP or pcDNA3.1-mCherry using BamHI/NheI-restriction sites, resulting in eukaryotic expression plasmids pc3-TFIIA α -, pc3-TFIIA β -, pc3-TFIIA γ -, and pc3-TFIIA Isoform2 -GFP or -mCherry. Plasmids pc3-TFIIA uncleav -, pc3-TFIIA NESmut -, pc3-TFIIA uncleavNESmut -, pc3-TFIIA W376A -, pc3-TFIIA Δ342-376 -, pc3-TFIIA uncleavW376A -, and pc3-TFIIA uncleavΔ342-376 -GFP were generated by splice overlap extension polymerase chain reaction (SOE-PCR) using appropriate primer combinations and templates as reported (Knauer et al., 2007a; Bier et al., 2011a) . A selection of variants was further subcloned into a pcDNA3.1 vector containing an additional N-terminal GSTtag using BamHI/NheI-restriction sites or fused to an N-terminal myc expression tag inserted via oligo annealing as outlined (Bier et al., 2011a) . Constructs for prokaryotic protein expression were generated by sucloning the respective inserts into pGEX3-GST_GFP using BamHI/NheI-restriction sites, resulting in the plasmids pGEX3-GST-TFIIA-GFP and the deletion mutant pGEX3-GST-TFIIA 1-40 -GFP. pGEX3-GST-TFIIA 1-40NESmut -GFP was generated by splice overlap extension polymerase chain reaction (SOE-PCR) as reported (Knauer et al., 2007a; Bier et al., 2011a) , pGEX3-GST-PKI_NES-GFP containing the NES of PKI was described before. Luciferase reporter constructs pRLSV40, pGL3 basic containing renilla or firefly luciferase, respectively (Promega), and pGL3 basic-wt p16INK4a 5′-UTR, additionally containing the wt p16INK4a 5′-UTR as part of the cdnk2a gene locus were described (Bisio et al., 2010) . Plasmids were verified by sequence analysis (Habtemichael et al., 2010b) . A detailed list of all used plasmids can be found in Supplementary Table S1 .
Protein extraction, immunoblot analysis, and immunofluorescence Preparation of whole cell lysates was carried out as described using a low salt lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40, 1 mM DTT, 1 mM PMSF, Complete EDTAfree from Roche Diagnostics) (Fetz et al., 2009a) . Equal loading of lysates was controlled by reprobing blots for GAPDH as described (Krämer et al., 2009) . Immunofluorescence was performed as reported in detail (Knauer et al., 2010; Bier et al., 2011b) .
Pull down experiments
In vitro coupled transcription/translation was performed using the TNT reticulocyte lysate system (Promega) supplemented with Methionine (Promega) and p_Crm1-HA as template. For pull down experiments, indicated p_Gex-TF2A-GFP plasmids and GSTRanQ96L were recombinantly expressed and purified as described (Stauber et al., 2006) . The indicated GST-TF2A-GFP (100 μl), prebound to 25 μl GST-Sepharose beads (GE Healthcare), was incubated with 10 μl GST-RanQ96L, 20 μl Crm1-HA in 5 mM MgCl 2 (AppliChem), 2 mM GTP (PEQLAB), 50 mM Hepes pH 7.9 (AppliChem), 200 mM KCl (AppliChem), 0.4% Tween 20 (AppliChem), and complete protease inhibitor cocktail (Roche).
Immunoprecipitation
IP of endogenous TBP was performed using α-TBP (Abcam), μ-MACS ProteinG MicroBeads and μ-magnetic antibody cell sorting (MACS) columns (Milteny Biotec) according to the suppliers' recommendation. Briefly, whole-cell lysates were incubated with 0.7 μl α-TBP and 50 μl μ-MACS ProteinG MicroBeads for 30 min on ice. μ-MACS columns were placed into the magnetic field stand and equilibrated with 200 μl lysis buffer. Lysates with magnetic beads were applied onto the columns, washed four times with 200 μl lysis buffer and once with 100 μl wash buffer-2 (Milteny Biotec). Afterwards, 20 μl pre-heated elution buffer (Milteny Biotec) was applied onto each column and incubated for 5 min. To complete protein elution, 50 μl pre-heated elution buffer was applied. Thirty microliters of the eluate, as well as 3% of the input were analyzed.
Cell proliferation and reporter gene assays
Cell viability was measured using the CellTiter-Glo ® Luminescent Cell Viability Assay (Promega) as specified by the manufacturer. For luciferase reporter gene assays, 5 × 10 4 293T
cells seeded in 24-well plates 24 h before transfection. Cells were transfected at 80% confluence using PEI (2.7 μl PEI per μg DNA) as described (Stauber et al., 2012) . Specifically, 350 ng of either the empty pGL3 basic or the pGL3 basic reporter vector containing the wt p16INK4a 5′-UTR were used along with 50 ng of the control pRLSV40 plasmid introduced to normalize transfection efficiency and 200 ng of the respective TFIIA variants or pc3-GFP as negative control. Cells were harvested 24 h after transfection, and luciferase assays were carried out using the dual-luciferase reagent (Promega) as described (Bisio et al., 2010) . Briefly, relative light units (RLU) were measured for both luciferases, firefly and renilla, normalized for transfection efficiency and plotted as fold-induction relative to the corresponding empty pGL3 basic vector co-transfection control for each TFIIA variant. Assays were performed in triplicate (technical replicate), and data shown are representative for at least three independent experiments (biological replicate).
otherwise, P-values represent data obtained from three independent experiments done in triplicate. P-values < 0.05 were considered as significant. Quantification of signal intensities was performed by densitometric analysis using ImageJ software (US National Institutes of Health) with 8-bit converted images.
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